UVM/FAHC
Welcome,         Profile    Billing    Logout  
 8 Trials 
9 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sholler, Giselle
NCT01586260: Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission

Active, not recruiting
2
89
US
DFMO, eflornithine HCl, Difluoromethylornithine
Giselle SaulnierSholler, Cancer Prevention Pharmaceuticals, Inc., University of Arizona, University of Hawaii, University of Vermont, Beat NB Cancer Foundation
Neuroblastoma
04/21
04/21
NCT04301843: Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma

Recruiting
2
131
Canada, US
Eflornithine, DFMO, difluoromethylornithine
Giselle Sholler, K C Pharmaceuticals Inc., Beat NB Cancer Foundation, Team Parker for Life
Neuroblastoma
10/28
10/33
PEDS-PLAN, NCT02559778: Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

Recruiting
2
500
Canada, US
Ceritinib, Zykadia, dasatinib, Sprycel, sorafenib, Nexavar, vorinostat, ZOLINZA, DFMO, Eflornithine, α-difluoromethylornithine
Giselle Sholler, Dell, Inc., Beat NB Cancer Foundation, K C Pharmaceuticals Inc., Team Parker for Life
Neuroblastoma
09/30
09/35
NCT06465199: Difluoromethylornithine (DFMO) and AMXT-1501 for Neuroblastoma, CNS Tumors, and Sarcomas

Not yet recruiting
1/2
253
NA
Difluoromethylornithine (DFMO), Eflornithine, AMXT-1501 Dicaprate
Milton S. Hershey Medical Center, Aminex Therapeutics, Inc.
Atypical Teratoid/Rhabdoid Tumor, Neuroblastoma Recurrent, Embryonal Tumor With Multilayered Rosettes, DIPG Brain Tumor, Ewing Sarcoma, Osteosarcoma Recurrent
02/33
02/35
NCT04238819: A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Active, not recruiting
1/2
117
Europe, Japan, US, RoW
Abemaciclib, LY2835219, Irinotecan, Temozolomide, Dinutuximab, GM-CSF
Eli Lilly and Company
Relapsed Solid Tumor, Refractory Solid Tumor
03/24
04/25
NCT04023331: 67Cu-SARTATE™ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk, Relapsed, Refractory Neuroblastoma

Recruiting
1/2
34
US
67Cu-SARTATE, Cu-67 SARTATE, copper 67 SARTATE, 64Cu-SARTATE, Cu-64 SARTATE, copper 64 SARTATE
Clarity Pharmaceuticals Ltd
Neuroblastoma, Relapsed Neuroblastoma, Refractory Neuroblastoma
12/28
12/28
NCT03581240: An Intermediate Expanded Use Trial of DFMO

Available
N/A
US
eflornithine HCl, DFMO
Giselle Sholler, K C Pharmaceuticals Inc., USWM, LLC
Neuroblastoma, Medulloblastoma, Typical Teratoid Rhabdoid Tumor, Embryonal Tumor With Abundant Neuropil and True Rosettes, Ependymoblastoma, Medulloepithelioma
 
 
NCT01802567: Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer

Completed
N/A
52
US
Guided Therapy- Pediatric Gene Analysis Platform, Molecular Guided Therapy
Giselle Sholler, Dell, Inc.
Neuroblastoma, Medulloblastoma, Brain Tumors, Rare Tumors
01/24
01/24
NCT02162732: Molecular-Guided Therapy for Childhood Cancer

Completed
N/A
186
US, RoW
Guided Therapy
Giselle Sholler, Translational Genomics Research Institute, Dell, Inc.
Neuroblastoma, Medulloblastoma, Glioma, Ependymoma, Choroid Plexus Neoplasms, Craniopharyngioma, Dysembryoplastic Neuroepithelial Tumor, Meningioma, Primitive Neuroectodermal Tumors (PNETs), Germ Cell Tumors, Rhabdomyosarcoma, Non-rhabdomyosarcoma, Ewings Sarcoma, Osteosarcoma, Wilms Tumor, Renal Cell Carcinoma, Malignant Rhabdoid Tumor, Clear Cell Sarcoma, Liver Tumors
01/24
01/24

Download Options